Alastair P Droop

11PUBLICATIONS
62CO-AUTHORS
Solid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 19, 2025
Wnt/β-catenin activation by mutually exclusive FBXW11 and CTNNB1 hotspot mutations drives salivary basal cell adenoma.

Kim Wong, Justin A Bishop, Ilan Weinreb

|Nov 07, 2024
Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy.

Louise van der Weyden, Martin Del Castillo Velasco-Herrera, Saamin Cheema

|Oct 11, 2024
Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.

Louise van der Weyden, Martin Del Castillo Velasco-Herrera, Saamin Cheema

|Aug 12, 2022
Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939.

Anke Brüning-Richardson, Gary C Shaw, Daniel Tams

|Nov 05, 2021
Benchmarking pipelines for subclonal deconvolution of bulk tumour sequencing data.

Georgette Tanner, David R Westhead, Alastair Droop

|Jun 22, 2021
The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma.

Ingrid Ferreira, Alastair Droop, Olivia Edwards

Pageof 2

Frequent Collaborators

4 joint publications

David J Adams

4 joint publications

Ingrid Ferreira

4 joint publications

Louise van der Weyden

3 joint publications

Mark J Arends